CD34+ Enriched Transplant

A Phase II Trial of CD34+ Enriched Transplants From HLA-Compatible Related or Unrelated Donors for Treatment of Patients With Myelodysplastic Syndrome

More Information

Trial Status
Not currently accepting
Trial Phase
Phase 2
Enrollment
50 patients (estimated)
Tags
Allogeneic Stem Cell Transplant, T Cell, CD34
Trial Type
Treatment
Last Update
2 weeks ago
SparkCures ID
1497
NCT Identifier
NCT05617625

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.